Boehringer Wins Again as California Judge Tosses Pradaxa Lawsuit

Drug Industry Daily
A A
A California judge ruled in Boehringer Ingelheim’s favor in another court case involving its blockbuster blood thinner Pradaxa (dabigatran) and allegations of fraud and failure to warn about the drug’s risks.

To View This Article:

Login

Subscribe To Drug Industry Daily